Skip to main content

Roche Holdings Ltd ADR(RHHBY)
OTC US

Today's Change
Delayed Last Update
Volume

Roche Holdings Ltd ADR

GRENZACHERSTRASSE 124
BASEL V8 CH-4070 CHE
P: 41-61-688-1111
http://www.roche.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its operations through two segments ' Pharmaceuticals and Diagnostics.Pharmaceuticals: Key focus areas in this segment include Oncology, Virology, Inflammation, Metabolism and Neuroscience. Diagnostics: The Diagnostics Division operates in four segments ' Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics. In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc.

    Key Executives

    NameTitle
    Information not available.